Effect of branched-chain amino acids in patients receiving intervention for hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 20, Issue 10, 2014, Pages 2673-2680

  Ishihara, Tomoaki ^a   Iwasa, Motoh ^b   Tanaka, Hideaki ^b   Kaito, Masahiko ^c   Ikoma, Jiro ^c   Shibata, Toshiya ^d   Takei, Yoshiyuki ^b  

^a Department of Gastroenterology and Hepatology Yokkaichi Digestive Disease Center   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Mie Shokakinaika ^*  (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Branched chain amino acids; Cirrhosis; Hepatocellular carcinoma; Hypoalbuminemia; Radiofrequency ablation; Transarterial chemoembolization

Indexed keywords

AMINOTRANSFERASE; BRANCHED CHAIN AMINO ACID; C REACTIVE PROTEIN; LIVACT; SERUM ALBUMIN; UNCLASSIFIED DRUG; ALB PROTEIN, HUMAN;

AGED; ARTICLE; BODY TEMPERATURE; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; ADVERSE EFFECTS; BLOOD; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DIET SUPPLEMENTATION; DRUG ADMINISTRATION; DRUG EFFECTS; LIVER NEOPLASMS; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; THERMOREGULATION; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; AMINO ACIDS, BRANCHED-CHAIN; BODY TEMPERATURE REGULATION; C-REACTIVE PROTEIN; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOALBUMINEMIA; LIVER NEOPLASMS; MALE; RETROSPECTIVE STUDIES; SERUM ALBUMIN; TIME FACTORS; TRANSAMINASES; TREATMENT OUTCOME;

EID: 84896870375     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i10.2673     Document Type: Article

References (26)

1. Koda M, Ueki M, Maeda Y, Mimura KI, Okamoto K, Matsunaga Y, Kawakami M, Hosho K, Murawaki Y. The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular carcinoma. Hepatol Res 2004; 29: 18-23 [PMID: 15135342]
2. Les I, Doval E, Flavià M, Jacas C, Cárdenas G, Esteban R, Guardia J, Córdoba J. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol 2010; 22: 221-227 [PMID: 19794311 DOI: 10.1097/MEG.0b013e3283319975]
3. Shiraki M, Nishiguchi S, Saito M, Fukuzawa Y, Mizuta T, Kaibori M, Hanai T, Nishimura K, Shimizu M, Tsurumi H, Moriwaki H. Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011. Hepatol Res 2013; 43: 106-112 [PMID: 23409849 DOI: 10.1111/ hepr.12004]
4. Kawaguchi T, Izumi N, Charlton MR, Sata M. Branchedchain amino acids as pharmacological nutrients in chronic liver disease. Hepatology 2011; 54: 1063-1070 [PMID: 21563202 DOI: 10.1002/hep.24412]
5. Nishikawa H, Osaki Y. Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma. Hepatol Res 2014; 44: 149-158 [PMID: 23819582 DOI: 10.1111/hepr.12194]
6. Limquiaco JL, Wong GL, Wong VW, Lai PB, Chan HL. Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma. J Gastroenterol Hepatol 2009; 24: 63-69 [PMID: 19054256 DOI: 10.1111/j.1440-1746.2008.05701.x]
7. Huang L, Li J, Yan JJ, Liu CF, Wu MC, Yan YQ. Prealbumin is predictive for postoperative liver insufficiency in patients undergoing liver resection. World J Gastroenterol 2012; 18: 7021-7025 [PMID: 23323003 DOI: 10.3748/wjg.v18.i47.7021]
8. Ishikawa T. Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma. World J Gastroenterol 2012; 18: 2005-2008 [PMID: 22563186 DOI: 10.3748/wjg.v18.i17.2005]
9. Usui T, Moriwaki H, Hatakeyama H, Kasai T, Kato M, Seishima M, Okuno M, Ohnishi H, Yoshida T, Muto Y. Oral supplementation with branched-chain amino acids improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis. J Nutr 1996; 126: 1412-1420 [PMID: 8618138]
10. Suzuki K, Suzuki K, Koizumi K, Ichimura H, Oka S, Takada H, Kuwayama H. Measurement of serum branched-chain amino acids to tyrosine ratio level is useful in a prediction of a change of serum albumin level in chronic liver disease. Hepatol Res 2008; 38: 267-272 [PMID: 18021234]
11. Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 2010; 26: 482-490 [PMID: 20071143 DOI: 10.1016/j.nut.2009.06.027]
12. Ishikawa T. Early administration of branched-chain amino acid granules. World J Gastroenterol 2012; 18: 4486-4490 [PMID: 22969221 DOI: 10.3748/wjg.v18.i33.4486]
13. Hidaka H, Nakazawa T, Kutsukake S, Yamazaki Y, Aoki I, Nakano S, Asaba N, Minamino T, Takada J, Tanaka Y, Okuwaki Y, Watanabe M, Shibuya A, Koizumi W. The efficacy of nocturnal administration of branched-chain amino acid granules to improve quality of life in patients with cirrhosis. J Gastroenterol 2013; 48: 269-276 [PMID: 22825550 DOI: 10.1007/s00535-012-0632-x]
14. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-713 [PMID: 16206505]
15. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Rossi Fanelli F, Abbiati R. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003; 124: 1792-1801 [PMID: 12806613]
16. Plauth M, Cabré E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, Ferenci P, Holm E, Vom Dahl S, Müller MJ, Nolte W. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006; 25: 285-294 [PMID: 16707194]
17. Fukushima H, Miwa Y, Shiraki M, Gomi I, Toda K, Kuriyama S, Nakamura H, Wakahara T, Era S, Moriwaki H. Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis. Hepatol Res 2007; 37: 765-770 [PMID: 17573945]
18. Kuwahata M, Kubota H, Katsukawa M, Ito S, Ogawa A, Kobayashi Y, Nakamura Y, Kido Y. Effect of branched-chain amino acid supplementation on the oxidized/reduced state of plasma albumin in rats with chronic liver disease. J Clin Biochem Nutr 2012; 50: 67-71 [PMID: 22247603 DOI: 10.3164/ jcbn.11-37]
19. Schieke SM, Phillips D, McCoy JP, Aponte AM, Shen RF, Balaban RS, Finkel T. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 2006; 281: 27643-27652 [PMID: 16847060]
20. Cabibbo G, Latteri F, Antonucci M, Craxì A. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol 2009; 6: 159-169 [PMID: 19190599 DOI: 10.1038/ncpgasthep1357]
21. Ijichi C, Matsumura T, Tsuji T, Eto Y. Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun 2003; 303: 59-64 [PMID: 12646166]
22. Matsumura T, Morinaga Y, Fujitani S, Takehana K, Nishitani S, Sonaka I. Oral administration of branched-chain amino acids activates the mTOR signal in cirrhotic rat liver. Hepatol Res 2005; 33: 27-32 [PMID: 16169275]
23. Takeshita S, Ichikawa T, Nakao K, Miyaaki H, Shibata H, Matsuzaki T, Muraoka T, Honda T, Otani M, Akiyama M, Miuma S, Ozawa E, Fujimito M, Eguchi K. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Nutr Res 2009; 29: 89-93 [PMID: 19285598 DOI: 10.1016/j.nutres.2008]
24. Nishikawa H, Osaki Y, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Henmi S, Sakamoto A, Ishikawa T, Saito S, Kita R, Kimura T. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2012; 18: 1379-1384 [PMID: 22493552 DOI: 10.3748/wjg.v18.i12.1379]
25. Iwasa J, Shimizu M, Shiraki M, Shirakami Y, Sakai H, Terakura Y, Takai K, Tsurumi H, Tanaka T, Moriwaki H. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Sci 2010; 101: 460-467 [PMID: 19906067 DOI: 10.1111/j.1349-7006.2009.01402.x]
26. Kuwahata M, Kubota H, Kanouchi H, Ito S, Ogawa A, Kobayashi Y, Kido Y. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease. Nutr Res 2012; 32: 522-529 [PMID: 22901560 DOI: 10.1016/j.nutres.2012.06.007]